nach oben

Clinical Reviews in Allergy & Immunology

Erschienen in:

01.04.2010

Mold and Human Health: Separating the Wheat from the Chaff

verfasst von: H. David Pettigrew, Carlo F. Selmi, Suzanne S. Teuber, M. Eric Gershwin

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 2-3/2010

Einloggen, um Zugang zu erhalten

Abstract

The term “mold” is utilized to define the ubiquitous fungal species commonly found in household dust and observed as visible multicellular filaments. Several well-defined human diseases are known to be caused or exacerbated by mold or by exposure to their byproducts. Among these, a solid connection has been established with infections, allergic bronchopulmonary aspergillosis, allergic fungal rhinosinusitis, hypersensitivity pneumonitis, and asthma. In the past decades, other less-defined and generally false conditions have also been ascribed to mold. We will herein review and critically discuss the available evidence on the influence of mold on human health.

Richard JL (2007) Some major mycotoxins and their mycotoxicoses—an overview. Int J Food Microbiol 119:3–10CrossRefPubMed

Boermans HJ, Leung MC (2007) Mycotoxins and the pet food industry: toxicological evidence and risk assessment. Int J Food Microbiol 119:95–102CrossRefPubMed

Stenske KA, Smith JR, Newman SJ, Newman LB, Kirk CA (2006) Aflatoxicosis in dogs and dealing with suspected contaminated commercial foods. J Am Vet Med Assoc 228:1686–1691CrossRefPubMed

Henghold WB 2nd (2004) Other biologic toxin bioweapons: ricin, staphylococcal enterotoxin B, and trichothecene mycotoxins. Dermatol Clin 22:257–262 vCrossRefPubMed

Roponen M, Seuri M, Nevalainen A, Hirvonen MR (2002) Fungal spores as such do not cause nasal inflammation in mold exposure. Inhal Toxicol 14:541–549CrossRefPubMed

Schleibinger H, Laussmann D, Bornehag CG, Eis D, Rueden H (2008) Microbial volatile organic compounds in the air of moldy and mold-free indoor environments. Indoor Air 18:113–124CrossRefPubMed

Hamill R (2001) Infectious Diseases: Mycotic. In: Tierney L, McPhee S, Papadakis M (eds) Current Medical Diagnosis and Treatment 2001. Lange Medical Books/McGraw-Hill, New York, pp 1481–1493

Bush RK, Portnoy JM, Saxon A, Terr AI, Wood RA (2006) The medical effects of mold exposure. J Allergy Clin Immunol 117:326–333CrossRefPubMed

Agarwal R (2009) Allergic bronchopulmonary aspergillosis. Chest 135:805–826CrossRefPubMed

10.

Greenberger PA (2002) Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 110:685–692CrossRefPubMed

11.

Greenberger PA, Patterson R (1988) Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 81:646–650CrossRefPubMed

12.

Seltzer JM, Fedoruk MJ (2007) Health effects of mold in children. Pediatr Clin North Am 54:309–333 viii-ixCrossRefPubMed

13.

Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE (1977) Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 86:405–414PubMed

14.

Luong A, Marple B (2005) The role of fungi in chronic rhinosinusitis. Otolaryngol Clin North Am 38:1203–1213CrossRefPubMed

15.

Luong A, Marple BF (2004) Allergic fungal rhinosinusitis. Curr Allergy Asthma Rep 4:465–470CrossRefPubMed

16.

Ryan MW, Marple BF (2007) Allergic fungal rhinosinusitis: diagnosis and management. Curr Opin Otolaryngol Head Neck Surg 15:18–22CrossRefPubMed

17.

Manning SC, Holman M (1998) Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngoscope 108:1485–1496CrossRefPubMed

18.

Bent JP 3rd, Kuhn FA (1994) Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 111:580–588CrossRefPubMed

19.

Ebbens FA, Fokkens WJ (2008) The mold conundrum in chronic rhinosinusitis: where do we stand today? Curr Allergy Asthma Rep 8:93–101CrossRefPubMed

20.

Ebbens FA, Georgalas C, Fokkens WJ (2009) Fungus as the cause of chronic rhinosinusitis: the case remains unproven. Curr Opin Otolaryngol Head Neck Surg 17:43–49CrossRefPubMed

21.

Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, Cardesin A, Bachert C, van Zele TP, Dijkgraaf MG, Lund V, Fokkens WJ (2006) Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 118:1149–1156CrossRefPubMed

22.

Kennedy DW, Kuhn FA, Hamilos DL, Zinreich SJ, Butler D, Warsi G, Pfister PJ, Tavakkol A (2005) Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope 115:1793–1799CrossRefPubMed

23.

Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H (2004) Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 113:1122–1128CrossRefPubMed

24.

Girard M, Lacasse Y, Cormier Y (2009) Hypersensitivity pneumonitis. Allergy 64:322–334CrossRefPubMed

25.

Kurup VP, Zacharisen MC, Fink JN (2006) Hypersensitivity pneumonitis. Indian J Chest Dis Allied Sci 48:115–128PubMed

26.

Baur X (1995) Hypersensitivity pneumonitis (extrinsic allergic alveolitis) induced by isocyanates. J Allergy Clin Immunol 95:1004–1010CrossRefPubMed

27.

Yoshizawa Y, Ohtsuka M, Noguchi K, Uchida Y, Suko M, Hasegawa S (1989) Hypersensitivity pneumonitis induced by toluene diisocyanate: sequelae of continuous exposure. Ann Intern Med 110:31–34PubMed

28.

Harrison LC, Honeyman MC, Morahan G, Wentworth JM, Elkassaby S, Colman PG, Fourlanos S (2008) Type 1 diabetes: lessons for other autoimmune diseases? J Autoimmun 31:306–310CrossRefPubMed

29.

Rieger R, Gershwin ME (2007) The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 28:76–84CrossRefPubMed

30.

Richerson HB, Bernstein IL, Fink JN, Hunninghake GW, Novey HS, Reed CE, Salvaggio JE, Schuyler MR, Schwartz HJ, Schwartz HJ, Stechschulte DJ (1989) Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol 84:839–844CrossRefPubMed

31.

Monkare S, Haahtela T (1987) Farmer’s lung—a 5-year follow-up of eighty-six patients. Clin Allergy 17:143–151CrossRefPubMed

32.

Delfino RJ, Zeiger RS, Seltzer JM, Street DH, Matteucci RM, Anderson PR, Koutrakis P (1997) The effect of outdoor fungal spore concentrations on daily asthma severity. Environ Health Perspect 105:622–635CrossRefPubMed

33.

Black PN, Udy AA, Brodie SM (2000) Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 55:501–504CrossRefPubMed

34.

Bush RK, Prochnau JJ (2004) Alternaria-induced asthma. J Allergy Clin Immunol 113:227–234CrossRefPubMed

35.

O’Driscoll BR, Hopkinson LC, Denning DW (2005) Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med 5:4CrossRefPubMed

36.

Pulimood TB, Corden JM, Bryden C, Sharples L, Nasser SM (2007) Epidemic asthma and the role of the fungal mold Alternaria alternata. J Allergy Clin Immunol 120:610–617CrossRefPubMed

37.

Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM (2006) The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 27:615–626CrossRefPubMed

38.

Neukirch C, Henry C, Leynaert B, Liard R, Bousquet J, Neukirch F (1999) Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Allergy Clin Immunol 103:709–711CrossRefPubMed

39.

Niedoszytko M, Chelminska M, Jassem E, Czestochowska E (2007) Association between sensitization to Aureobasidium pullulans (Pullularia sp) and severity of asthma. Ann Allergy Asthma Immunol 98:153–156CrossRefPubMed

40.

Simon-Nobbe B, Denk U, Poll V, Rid R, Breitenbach M (2008) The spectrum of fungal allergy. Int Arch Allergy Immunol 145:58–86CrossRefPubMed

41.

Dales RE, Cakmak S, Judek S, Dann T, Coates F, Brook JR, Burnett RT (2003) The role of fungal spores in thunderstorm asthma. Chest 123:745–750CrossRefPubMed

42.

Belanger K, Beckett W, Triche E, Bracken MB, Holford T, Ren P, McSharry JE, Gold DR, Platts-Mills TA, Leaderer BP (2003) Symptoms of wheeze and persistent cough in the first year of life: associations with indoor allergens, air contaminants, and maternal history of asthma. Am J Epidemiol 158:195–202CrossRefPubMed

43.

Gent JF, Ren P, Belanger K, Triche E, Bracken MB, Holford TR, Leaderer BP (2002) Levels of household mold associated with respiratory symptoms in the first year of life in a cohort at risk for asthma. Environ Health Perspect 110:A781–786PubMed

44.

Andersson M, Downs S, Mitakakis T, Leuppi J, Marks G (2003) Natural exposure to Alternaria spores induces allergic rhinitis symptoms in sensitized children. Pediatr Allergy Immunol 14:100–105CrossRefPubMed

45.

Gergen PJ, Turkeltaub PC (1992) The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976–80 (NHANES II). J Allergy Clin Immunol 90:579–588CrossRefPubMed

46.

Helbling A, Gayer F, Pichler WJ, Brander KA (1998) Mushroom (Basidiomycete) allergy: diagnosis established by skin test and nasal challenge. J Allergy Clin Immunol 102:853–858CrossRefPubMed

47.

Rowe MS, Bailey J, Ownby DR (1986) Evaluation of the cause of nasal and ocular symptoms associated with lawn mowing. J Allergy Clin Immunol 77:714–719CrossRefPubMed

48.

Katz Y, Verleger H, Barr J, Rachmiel M, Kiviti S, Kuttin ES (1999) Indoor survey of moulds and prevalence of mould atopy in Israel. Clin Exp Allergy 29:186–192CrossRefPubMed

49.

Lander F, Meyer HW, Norn S (2001) Serum IgE specific to indoor moulds, measured by basophil histamine release, is associated with building-related symptoms in damp buildings. Inflamm Res 50:227–231CrossRefPubMed

50.

Montealegre F, Meyer B, Chardon D, Vargas W, Zavala D, Hart B, Bayona M (2004) Comparative prevalence of sensitization to common animal, plant and mould allergens in subjects with asthma, or atopic dermatitis and/or allergic rhinitis living in a tropical environment. Clin Exp Allergy 34:51–58CrossRefPubMed

51.

Reijula K, Leino M, Mussalo-Rauhamaa H, Nikulin M, Alenius H, Mikkola J, Elg P, Kari O, Makinen-Kiljunen S, Haahtela T (2003) IgE-mediated allergy to fungal allergens in Finland with special reference to Alternaria alternata and Cladosporium herbarum. Ann Allergy Asthma Immunol 91:280–287CrossRefPubMed

52.

Scalabrin DM, Bavbek S, Perzanowski MS, Wilson BB, Platts-Mills TA, Wheatley LM (1999) Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol 104:1273–1279CrossRefPubMed

53.

Boguniewicz M, Schmid-Grendelmeier P, Leung DY (2006) Atopic dermatitis. J Allergy Clin Immunol 118:40–43CrossRefPubMed

54.

Leung DY (2000) Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105:860–876CrossRefPubMed

55.

Casagrande BF, Fluckiger S, Linder MT, Johansson C, Scheynius A, Crameri R, Schmid-Grendelmeier P (2006) Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema. J Invest Dermatol 126:2414–2421CrossRefPubMed

56.

Johansson C, Sandstrom MH, Bartosik J, Sarnhult T, Christiansen J, Zargari A, Back O, Wahlgren CF, Faergemann J, Scheynius A, Tengvall Linder M (2003) Atopy patch test reactions to Malassezia allergens differentiate subgroups of atopic dermatitis patients. Br J Dermatol 148:479–488CrossRefPubMed

57.

Zargari A, Eshaghi H, Back O, Johansson S, Scheynius A (2001) Serum IgE reactivity to Malassezia furfur extract and recombinant M. furfur allergens in patients with atopic dermatitis. Acta Derm Venereol 81:418–422CrossRefPubMed

58.

Elagin RB, Balijepalli S, Diacovo MJ, Baekkeskov S, Jaume JC (2009) Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice. J Autoimmun 33:50–57CrossRefPubMed

59.

Gebe JA, Unrath KA, Yue BB, Miyake T, Falk BA, Nepom GT (2008) Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice. J Autoimmun 30:197–206CrossRefPubMed

60.

Hogan TV, Ang DK, Gleeson PA, van Driel IR (2008) Extrathymic mechanisms of T cell tolerance: lessons from autoimmune gastritis. J Autoimmun 31:268–273CrossRefPubMed

61.

Jordan MA, Baxter AG (2008) The genetics of immunoregulatory T cells. J Autoimmun 31:237–244CrossRefPubMed

62.

Maverakis E, Beech JT, Schneider S, Sercarz EE (2008) Presentation of a determinant by MHC class II can be prevented through competitive capture by a flanking determinant on a multideterminant peptide. J Autoimmun 31:59–65CrossRefPubMed

63.

Morahan G, Peeva V, Mehta M, Williams R (2008) Systems genetics can provide new insights in to immune regulation and autoimmunity. J Autoimmun 31:233–236CrossRefPubMed

64.

Pai S, Thomas R (2008) Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity. J Autoimmun 31:245–251CrossRefPubMed

65.

Papadimitraki ED, Bertsias GK, Boumpas DT (2007) Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 29:310–318PubMed

66.

Poletaev AB, Stepanyuk VL, Gershwin ME (2008) Integrating immunity: the immunculus and self-reactivity. J Autoimmun 30:68–73CrossRefPubMed

67.

Sanchez-Pernaute O, Ospelt C, Neidhart M, Gay S (2008) Epigenetic clues to rheumatoid arthritis. J Autoimmun 30:12–20CrossRefPubMed

68.

Youinou P, Jamin C (2009) The weight of interleukin-6 in B cell-related autoimmune disorders. J Autoimmun 32:206–210CrossRefPubMed

69.

Chang C, Gershwin ME (2005) Mold hysteria: origin of the hoax. Clin Dev Immunol 12:151–158CrossRefPubMed

70.

Terr AI (2009) Sick building syndrome: is mould the cause? Med Mycol 47(Suppl 1):S217–222CrossRefPubMed

71.

Tsai YJ, Gershwin ME (2002) The sick building syndrome: what is it when it is? Compr Ther 28:140–144CrossRefPubMed

72.

Redlich CA, Sparer J, Cullen MR (1997) Sick-building syndrome. Lancet 349:1013–1016CrossRefPubMed

73.

Terr AI (2001) Stachybotrys: relevance to human disease. Ann Allergy Asthma Immunol 87:57–63CrossRefPubMed

74.

Fatal fungus. (1998), Environ Health Perspect 106, A11-12.

75.

Pestka JJ, Yike I, Dearborn DG, Ward MD, Harkema JR (2008) Stachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: new insights into a public health enigma. Toxicol Sci 104:4–26CrossRefPubMed

76.

Johanning E, Biagini R, Hull D, Morey P, Jarvis B, Landsbergis P (1996) Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. Int Arch Occup Environ Health 68:207–218PubMed

77.

Hodgson MJ, Morey P, Leung WY, Morrow L, Miller D, Jarvis BB, Robbins H, Halsey JF, Storey E (1998) Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med 40:241–249CrossRefPubMed

78.

Nordness ME, Zacharisen MC, Fink JN (2003) Toxic and other non-IgE-mediated effects of fungal exposures. Curr Allergy Asthma Rep 3:438–446CrossRefPubMed

79.

Edmondson DA, Nordness ME, Zacharisen MC, Kurup VP, Fink JN (2005) Allergy and “toxic mold syndrome”. Ann Allergy Asthma Immunol 94:234–239CrossRefPubMed

80.

Borchers AT, Chang C, Keen CL, Gershwin ME (2006) Airborne environmental injuries and human health. Clin Rev Allergy Immunol 31:1–101CrossRefPubMed

81.

Acute pulmonary hemorrhage/hemosiderosis among infants—Cleveland, January 1993-November 1994. (1994), MMWR Morb Mortal Wkly Rep 43, 881-883

82.

Update: pulmonary hemorrhage/hemosiderosis among infants—Cleveland, Ohio, 1993-1996. (1997), MMWR Morb Mortal Wkly Rep 46, 33-35

83.

Etzel RA, Montana E, Sorenson WG, Kullman GJ, Allan TM, Dearborn DG, Olson DR, Jarvis BB, Miller JD (1998) Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 152:757–762PubMed

84.

Dearborn DG, Yike I, Sorenson WG, Miller MJ, Etzel RA (1999) Overview of investigations into pulmonary hemorrhage among infants in Cleveland, Ohio. Environ Health Perspect 107(Suppl 3):495–499PubMed

85.

From the Centers for Disease Control and Prevention. Update: pulmonary hemorrhage/hemosiderosis among infants—Cleveland, Ohio, 1993–1996. (2000), JAMA 283, 1951–1953

86.

Chapman JA, Terr AI, Jacobs RL, Charlesworth EN, Bardana EJ Jr (2003) Toxic mold: phantom risk vs science. Ann Allergy Asthma Immunol 91:222–232CrossRefPubMed

87.

Babcock DW (2006) The legal implications of “toxic” mold exposure. J Environ Health 68:50–51PubMed

Titel: Mold and Human Health: Separating the Wheat from the Chaff
verfasst von: H. David Pettigrew
Carlo F. Selmi
Suzanne S. Teuber
M. Eric Gershwin
Publikationsdatum: 01.04.2010
Verlag: Humana Press Inc
Erschienen in: Clinical Reviews in Allergy & Immunology / Ausgabe 2-3/2010
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-009-8175-5

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Mold and Human Health: Separating the Wheat from the Chaff

Abstract

Neu im Fachgebiet HNO

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Akuter Schwindel: Wann lohnt sich eine MRT?

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2-3/2010

The Pathogenesis of Neural Injury in Animal Models of the Antiphospholipid Syndrome

Sarcoidosis Presenting as “Corset-like” Myelopathy: A Description of Six Cases and Literature Review

Vaccination for Atherosclerosis

Antifibrosis: To Reverse the Irreversible

Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature

Contemporary Challenges in Mastocytosis

Neu im Fachgebiet HNO

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Akuter Schwindel: Wann lohnt sich eine MRT?

Update HNO